STRO · Sutro Biopharma, Inc.
$25.28
+1.13 (+4.68%)
At close · Aug 7
Market Cap
$400.18M
Shares
16.57M
Sutro Biopharma, Inc. Earnings Call Transcripts
Every quarterly earnings call for Sutro Biopharma, Inc. (STRO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼17.1%
$7.15M
−$19.59M
'20 Q1
20-04-27
▼32.7%
$16.92M
−$49.28M
'23 Q3
23-11-13
▲1217.4%
$113.72M
$31.07M
'23 Q4
24-03-25
▲2.6%
$13.01M
−$58.21M
'24 Q1
24-05-13
▲146.9%
$25.71M
−$48.02M
'24 Q2
24-08-13
▼49.7%
$8.52M
−$48.79M
'24 Q3
24-11-13
▼87%
$14.81M
−$72.44M
'24 Q4
25-03-13
▲33.8%
$17.40M
−$75.97M
'25 Q1
25-05-08
▲148%
$63.74M
−$11.50M
'25 Q2
25-08-07
▲13.8%
$9.69M
−$56.86M
'25 Q3
25-11-06
LATEST
▼16.5%
$14.52M
−$38.48M
'26 Q1
26-05-27
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-27
Sutro Biopharma, Inc. Q1 FY2026 Earnings Call
Revenue
$14.52M
▼ 16.5% YoY Diluted EPS
$-2.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q3
2025-11-06
Sutro Biopharma, Inc. Q3 FY2025 Earnings Call
Revenue
$9.69M
▲ 13.8% YoY Diluted EPS
$-6.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Sutro Biopharma, Inc. Q2 FY2025 Earnings Call
Revenue
$63.74M
▲ 148% YoY Diluted EPS
$-1.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Sutro Biopharma, Inc. Q1 FY2025 Earnings Call
Revenue
$17.40M
▲ 33.8% YoY Diluted EPS
$-9.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-13
Sutro Biopharma, Inc. Q4 FY2024 Earnings Call
Revenue
$14.81M*
▼ 87% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Sutro Biopharma, Inc. Q3 FY2024 Earnings Call
Revenue
$8.52M
▼ 49.7% YoY Diluted EPS
$-5.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Sutro Biopharma, Inc. Q2 FY2024 Earnings Call
Revenue
$25.71M
▲ 146.9% YoY Diluted EPS
$-5.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Sutro Biopharma, Inc. Q1 FY2024 Earnings Call
Revenue
$13.01M
▲ 2.6% YoY Diluted EPS
$-5.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-25
Sutro Biopharma, Inc. Q4 FY2023 Earnings Call
Revenue
$113.72M*
▲ 1217.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Sutro Biopharma, Inc. Q3 FY2023 Earnings Call
Revenue
$16.92M
▼ 32.7% YoY Diluted EPS
$-8.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-27
Sutro Biopharma, Inc. Q1 FY2020 Earnings Call
Revenue
$7.15M
▼ 17.1% YoY Diluted EPS
$-8.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–12 of 12 earnings calls
Key facts
CIK
1382101
CUSIP
869367201
13F (30d)
18 filings
18 filers
Visit website
Investor relations